Loading clinical trials...
Loading clinical trials...
A Pre-market, Open-label, Within Subject Study, of Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients Compared With the CP1150 Sound Processor and Their Current Sound Processor.
Conditions
Interventions
CP1170 Sound Processor
CP1150 Sound Processor
Locations
1
Australia
Cochlear Macquarie
Macquarie, Sydney, Australia
Start Date
December 20, 2022
Primary Completion Date
September 7, 2023
Completion Date
January 10, 2024
Last Updated
August 22, 2025
NCT05805384
NCT05641155
NCT05003674
NCT05936320
NCT02045511
NCT01816087
Lead Sponsor
Cochlear
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions